A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies

G.J. Ossenkoppele; B. Lowenberg; P. Zachee; N. Vey; D. Breems; A.A. van de Loosdrecht; A.H. Davidson; G. Wells; L. Needham; L. Bawden; M. Toal; L. Hooftman; P.M. Debnam

doi:https://doi.org/10.1111/bjh.12359

A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies

G.J. Ossenkoppele, B. Lowenberg, P. Zachee, N. Vey, D. Breems, A.A. van de Loosdrecht, A.H. Davidson, G. Wells, L. Needham, L. Bawden, M. Toal, L. Hooftman, P.M. Debnam

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

29 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	191-201
Journal	British journal of haematology
Volume	162
Issue number	2
DOIs	https://doi.org/10.1111/bjh.12359
Publication status	Published - 2013

Access to Document

https://doi.org/10.1111/bjh.12359

Cite this

Ossenkoppele, G. J., Lowenberg, B., Zachee, P., Vey, N., Breems, D., van de Loosdrecht, A. A., Davidson, A. H., Wells, G., Needham, L., Bawden, L., Toal, M., Hooftman, L., & Debnam, P. M. (2013). A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies. British journal of haematology, 162(2), 191-201. https://doi.org/10.1111/bjh.12359

@article{ce9c0641413b44ee96c61a056f7e278e,

title = "A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies",

author = "G.J. Ossenkoppele and B. Lowenberg and P. Zachee and N. Vey and D. Breems and {van de Loosdrecht}, A.A. and A.H. Davidson and G. Wells and L. Needham and L. Bawden and M. Toal and L. Hooftman and P.M. Debnam",

year = "2013",

doi = "https://doi.org/10.1111/bjh.12359",

language = "Undefined/Unknown",

volume = "162",

pages = "191--201",

journal = "British journal of haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "2",

}

Ossenkoppele, GJ, Lowenberg, B, Zachee, P, Vey, N, Breems, D, van de Loosdrecht, AA, Davidson, AH, Wells, G, Needham, L, Bawden, L, Toal, M, Hooftman, L & Debnam, PM 2013, 'A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies', British journal of haematology, vol. 162, no. 2, pp. 191-201. https://doi.org/10.1111/bjh.12359

A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies. / Ossenkoppele, G.J.; Lowenberg, B.; Zachee, P. et al.
In: British journal of haematology, Vol. 162, No. 2, 2013, p. 191-201.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies

AU - Ossenkoppele, G.J.

AU - Lowenberg, B.

AU - Zachee, P.

AU - Vey, N.

AU - Breems, D.

AU - van de Loosdrecht, A.A.

AU - Davidson, A.H.

AU - Wells, G.

AU - Needham, L.

AU - Bawden, L.

AU - Toal, M.

AU - Hooftman, L.

AU - Debnam, P.M.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1111/bjh.12359

DO - https://doi.org/10.1111/bjh.12359

M3 - Article

C2 - 23647373

SN - 0007-1048

VL - 162

SP - 191

EP - 201

JO - British journal of haematology

JF - British journal of haematology

IS - 2

ER -